FTC upholds POM decision

The Federal Trade Commission (FTC) has upheld a judge’s May ruling that POM Wonderful pomegranate juice brand made deceptive claims about the health benefits of its products, according to the Associated Press. The case centered on POM’s claims that its pomegranate juice could treat or prevent heart disease, prostate cancer and other conditions. The company also sells Pomegranate-derived pills and liquid extract. The FTC issued a final order barring POM’s marketers from making any future health claims unless they’re supported by two randomized, well-controlled, human studies.